Abstract | BACKGROUND: The shortage of organs is a limitation for transplantation, making the care of potential organ donors an important issue. The present systematic review and meta-analysis was carried out to assess the efficacy of interventions to stabilize hemodynamics in brain-dead donors or to improve organ function and outcomes of transplantation. METHODS: Medline, Embase, and Cochrane databases were searched. Of 5096 articles retrieved, 39 randomized controlled trials were selected. Twenty were included in a qualitative synthesis, providing data on 1277 patients. The main interventions described were desmopressin use, triiodothyronine and methylprednisolone replacement, fluid management, vasopressor therapy, mechanical ventilation strategies, and surgical techniques. RESULTS: Three meta-analyses were conducted: the first included two studies and showed that desmopressin administered to brain-dead patients was not advantageous with respect to early organ function in kidney recipients (relative risk, 0.97; 95% confidence interval [CI], 0.85-1.10; I(2) = 0%; P = 0.809). The second included four studies and showed that triiodothyronine did not add hemodynamic benefits versus standard management (weighted mean difference, 0.15; 95% CI, -0.13 to 0.42; I(2) = 17.4%; P = 0.304). The third meta-analysis (two studies) showed that ischemic liver preconditioning during harvesting procedures did not benefit survival (relative risk, 1.0; 95% CI, 0.93-1.08; I(2) = 0%; P = 0.459). CONCLUSION: The present results suggest limited efficacy of interventions focusing on the management of brain-dead donors.
|
Authors | Tatiana H Rech, Rafael B Moraes, Daisy Crispim, Mauro A Czepielewski, Cristiane B Leitão |
Journal | Transplantation
(Transplantation)
Vol. 95
Issue 7
Pg. 966-74
(Apr 15 2013)
ISSN: 1534-6080 [Electronic] United States |
PMID | 23545508
(Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Review, Systematic Review)
|
Chemical References |
- Vasoconstrictor Agents
- Triiodothyronine
- Deamino Arginine Vasopressin
- Methylprednisolone
|
Topics |
- Brain Death
(metabolism, physiopathology)
- Deamino Arginine Vasopressin
(administration & dosage)
- Fluid Therapy
- Hemodynamics
- Hormone Replacement Therapy
- Humans
- Methylprednisolone
(administration & dosage)
- Respiration, Artificial
- Tissue Donors
(supply & distribution)
- Tissue and Organ Harvesting
(methods)
- Tissue and Organ Procurement
- Transplants
(adverse effects)
- Triiodothyronine
(administration & dosage)
- Vasoconstrictor Agents
(administration & dosage)
|